Mild Cognitive Impairment (MCI)

Mild cognitive impairment (MCI) sits between normal age-related cognitive change and dementia: there is a measurable decline in memory or another cognitive domain, noticeable to the person or people around them, but independence in daily activities is largely preserved, distinguishing it from major neurocognitive disorder. MCI matters clinically because it identifies a group of people who need monitoring and risk-factor management, since some — though not all — will progress to dementia over time, while others remain stable or even improve, particularly when a treatable contributing cause such as depression, poor sleep or a medication side effect is identified and addressed. A diagnosis of MCI is not a diagnosis of dementia, and framing it that way to patients and families, while still taking it seriously, is an important part of good care.

Mild neurocognitive disorder is defined as modest cognitive decline from a previous level of performance in one or more cognitive domains, based on concern from the individual, a knowledgeable informant, or the clinician, along with objective evidence of impairment, where the deficits do not interfere with the capacity for independence in everyday activities, though greater effort, compensatory strategies or accommodation may be required.

MCI can be an early stage of an underlying neurodegenerative process, most often Alzheimer's disease pathology, in which case it may progress to dementia over subsequent years. It can also result from vascular risk factors, depression, chronic sleep deprivation, certain medications, thyroid dysfunction, vitamin B12 deficiency, or excessive alcohol use — causes that are often at least partly modifiable or reversible. Distinguishing between a likely neurodegenerative and a likely reversible or vascular cause, through history, examination and targeted investigation, shapes both the monitoring plan and realistic expectations for the person and family.

• Increasing age
• Family history of dementia
• Cardiovascular risk factors: hypertension, diabetes, high cholesterol
• Low cognitive and social engagement
• Untreated depression or chronic high stress
• Poor sleep quality or untreated sleep apnoea
• Carrying certain genetic risk factors, where known and tested

In cases progressing toward Alzheimer's disease, MCI is thought to reflect early accumulation of amyloid and tau pathology, initially affecting medial temporal lobe structures involved in memory formation, before compensatory brain networks are overwhelmed and clinical impairment becomes more pronounced and independence is affected. In vascular-related MCI, small-vessel disease disrupts white-matter connections important for processing speed and executive function. Cognitive reserve — built through education, ongoing mental stimulation, and cardiovascular health — is thought to explain why people with similar amounts of underlying brain change can show quite different levels of clinical impairment, and why lifestyle measures remain relevant even after a diagnosis of MCI.

• Noticeably more forgetful than before, such as misplacing items more often or repeating questions
• Difficulty following complex conversations, instructions or plots of a story
• Taking longer to complete familiar tasks, or needing more effort to concentrate
• Occasional lapses in judgment, though generally intact insight
• Mild word-finding difficulty
• The person and/or family notice a change, but daily independence — managing money, medications, cooking — is largely preserved

• Evidence of modest cognitive decline from a previous level in one or more cognitive domains, based on concern from the individual, an informant, or the clinician
• Objective evidence of modest impairment on cognitive testing, typically in a range below expectation for age and education but above the threshold for major impairment
• The cognitive deficits do not interfere with capacity for independence in everyday activities, though more effort or compensatory strategies may be needed
• The deficits do not occur exclusively in the context of delirium
• The deficits are not better explained by another mental disorder, such as depression

Conditions a psychiatrist will consider and rule out before confirming this diagnosis:

Major neurocognitive disorder (dementia)

The key distinguishing feature is preserved independence in daily activities in MCI, versus significant functional impairment in dementia.

Normal age-related cognitive change

Occasional, non-progressive forgetfulness without objective decline on testing and without informant concern is more consistent with normal ageing than MCI.

Depression

Depression in older adults commonly presents with concentration and memory complaints and can be difficult to distinguish from early cognitive decline without careful assessment and, sometimes, a treatment trial.

Delirium and medication effects

Both should be actively excluded, since they can produce a similar clinical picture that resolves once the underlying cause is treated.

• Detailed history from the person and an informant, including onset and progression
• Formal cognitive testing (such as MoCA), ideally with a baseline for future comparison
• Assessment of mood, sleep and medication use
• Blood tests: thyroid function, vitamin B12, folate, and metabolic screening
• Brain imaging where the presentation, age of onset or examination findings suggest a specific structural or vascular cause
• Functional assessment confirming preserved independence in daily activities

There is no medication currently approved specifically to treat MCI itself, so management centres on identifying and treating any contributing or reversible causes, addressing cardiovascular and lifestyle risk factors that influence progression risk, and establishing a monitoring plan with periodic reassessment, typically every six to twelve months or sooner if symptoms change. This is also an opportunity to have proactive conversations with the person and family about future planning while cognition and decision-making capacity remain largely intact, which is far preferable to having those conversations later under pressure.

No condition-specific medication is currently approved for MCI

Cholinesterase inhibitors are not routinely recommended for MCI itself; any medication decisions are individualised to a specific comorbid condition (such as depression) rather than applied generically.

Treatment of identified contributing conditions

Where depression, sleep apnoea, thyroid disease or vitamin deficiency is contributing, treating that condition directly can improve or stabilise cognitive symptoms.

Cognitive rehabilitation strategies

Structured use of memory aids, routines and compensatory strategies can support day-to-day function and confidence.

Treatment of comorbid anxiety or depression

Addressing mood symptoms directly, which are common alongside MCI and can themselves worsen cognitive performance, often brings real functional improvement.

• Stay physically active; regular aerobic exercise has some of the best evidence for supporting cognitive health
• Keep socially and mentally engaged through meaningful activities, learning and relationships
• Manage blood pressure, blood sugar and cholesterol proactively
• Prioritise consistent, good-quality sleep and address suspected sleep apnoea
• Limit alcohol and avoid smoking
• Use memory aids and routines early, rather than waiting until they feel strictly necessary
• Treat hearing and vision problems promptly

Outcomes in MCI vary: a proportion of people progress to dementia over the following years, particularly when an underlying neurodegenerative process is present, but a meaningful proportion remain stable, and some improve, especially when a treatable contributor such as depression, sleep apnoea or a vitamin deficiency is identified and treated. Regular follow-up allows progression to be identified early if it occurs, and gives the best opportunity to address modifiable risk factors that may slow decline.

• Manage cardiovascular risk factors across adulthood
• Stay physically, socially and cognitively active
• Treat depression, sleep problems and hearing loss promptly
• Limit alcohol intake and avoid smoking
• Seek assessment early for any persistent, noticeable change in memory or thinking

An MCI diagnosis is a reasonable prompt for planning, not a reason for alarm. Families can support the person by helping establish routines and memory aids without taking over tasks the person can still manage independently, since maintaining engagement in daily activities is itself protective. Encouraging regular follow-up, supporting a heart-healthy and socially active lifestyle, and having early, unpressured conversations about future wishes and planning are some of the most useful things a family can do at this stage.

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR).
2. National Institute for Health and Care Excellence (NICE). Dementia: assessment, management and support (covers MCI pathway).
3. Alzheimer's Association. Mild cognitive impairment clinical guidance.